DexCom Inc (DXCM) — Quality & forensics
As of 2026-10-09 — refreshed nightly. Closelooknet readings from an investment research diary, not ratings or advice.
The Closelooknet module scores
- Valuation 38
- Quality 80
- Growth 67
- Balance sheet 74
- Cash quality 59
- Capital allocation 54
- Momentum 81
Scores are computed nightly across the coverage universe and read relative to it — the methodology lives in the company-scoring explainer.
Financial forensics — the academic screens
Sits in the safe zone (above 2.99). The Z-Score estimates financial-distress risk from five balance-sheet and earnings ratios.
Nine binary fundamental-strength checks across profitability, leverage and operating efficiency.
Screens reported earnings for statistical manipulation patterns — below the −1.78 manipulation-risk threshold. A screen, not an accusation.
Continue: the DXCM chart & overview · the earnings record
FAQ · from the current data · as of 2026-10-09
Quick answers
What is DexCom Inc's Closelooknet quality reading?
The composite reads 66/100 across 7 modules, as of 2026-10-09: valuation 38, quality 80, growth 67, balance sheet 74, cash quality 59, capital allocation 54, momentum 81. Closelooknet scores are research diary readings, not ratings or investment advice.
What is DexCom Inc's Altman Z-Score?
7.36, which sits in the safe zone (above 2.99) as of 2026-10-09. The Altman Z-Score estimates financial distress risk from five balance-sheet and earnings ratios.
What is DexCom Inc's Piotroski F-Score?
7 of 9, as of 2026-10-09. The F-Score counts nine binary fundamental-strength signals across profitability, leverage and operating efficiency.
What does DexCom Inc's Beneish M-Score indicate?
-2.66 — below the −1.78 manipulation-risk threshold, as of 2026-10-09. The M-Score screens reported earnings for statistical manipulation patterns; it is a screen, not an accusation.
Related in the Closelooknet universe
same Closelooknet index seat first, then Medical Devices. Scored names rank on their Closelooknet score; names without one rank on trend state — above or below their 50- and 200-day averages — never on a score they do not carry.
- RACE Ferrari NV
- DECK Deckers Outdoor Corporation
- LLY Eli Lilly and Company
- TOST Toast Inc
- REGN Regeneron Pharmaceuticals Inc
- FSLR First Solar Inc
- GMED Globus Medical
- ONON On Holding Ltd
- ZEAL.CO Zealand Pharma A/S
- DB1.DE Deutsche Börse AG
- ISRG Intuitive Surgical Inc
- VRTX Vertex Pharmaceuticals Inc
- SECT-B.ST Sectra AB (publ)industry
- SOON.SW Sonova H Agindustry
- CEVI.ST CellaVision ABindustry
- SNN Smith & Nephew SNATS Incindustry
- SYK Stryker Corporationindustry
- GKOS Glaukos Corpindustry
- PACB Pacific Biosciences of Californiaindustry
- TXG 10X Genomics Incindustry